טוען...
HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade
Expression of PD-1 ligands by tumors and interaction with PD-1 expressing T cells in the tumor microenvironment can result in tolerance. Therapies targeting this co-inhibitory axis have proven clinically successful in the treatment of metastatic melanoma, non-small cell lung cancer and other maligna...
שמור ב:
| הוצא לאור ב: | Cancer Immunol Res |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4674300/ https://ncbi.nlm.nih.gov/pubmed/26297712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-15-0077-T |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|